期刊文献+

壳聚糖基纳米载药微粒的研究进展 被引量:6

Research Progress in the Drug-loaded Nanoparticles Derived from Chitosan
暂未订购
导出
摘要 多肽、蛋白质、核苷酸及质粒等复杂高分子的粘膜释放给药是当前最受关注的研究课题之一。壳聚糖作为一种天然高分子多糖,已经被认为是一种最具希望的高分子药物的跨膜输送载体。而壳聚糖纳米微粒是主要的载体形式之一。本文综述了壳聚糖纳米微粒药物载体的制备方法以及输送高分子药物的作用机制。现已表明壳聚糖可通过离子交联、共价交联、沉淀析出、大分子复合及自组装等方法获取负载大分子药物的壳聚糖纳米胶体粒子。结尾阐述了这种新型载药系统的存在的问题及应用前景。 Mucosal delivery of complex molecules such as peptides, proteins, oligonucleotides, and plasmids is of increasing interest in recent years, Using a hydrophilic polysaccharide (chitosan) as colloidal carriers has become a promising alternative for improving the transport of such macromolecules across biological surfaces. This article reviews the approaches to prepare drug-loaded nanoparticles derived from chitosan and the action mechanism of their efficacy in improvement of the transport of the associated molecule through biological surfaces. Chitosan can form colloidal particles and entrap macromolecules through a number of mechanisms, including ionic crosslinking, covalent crosslinking, desolvating, supramolecular complexation, or self-assemblies. The potential applications and prospects of these new systems for mucosal delivery ofmacromolecules are also highlighted.
出处 《现代食品科技》 EI CAS 2007年第4期89-92,共4页 Modern Food Science and Technology
关键词 壳聚糖 纳米 多肽 蛋白质 药物释放 chitosan nanoparticles peptide protein drug delivery
  • 相关文献

参考文献21

  • 1[1]Tanima B,Susmita M,Singh K,et al.Preparation,characterization and biodistribution of ultrafine chitosan nanoparticles[J].Int J Pharm,2002,243(1-2):93-102.
  • 2[2]Janes,K.A.,Calvo,P.,Alonso,M.J.,Polysaccharide colloidal particles as delivery systems for macromolecules,Adv.Drug Deliver.Rev.2001(47) 83.
  • 3[3]R.Bodmeier,H.Chen,O.Paeratakul,A.novel approach to the delivery of microparticles or nanoparticles,Pharm.Res.1989(6):413-417.
  • 4[4]Huang M,MA ZS,Khor E,et al.Uptake of FITC-chitosan nanoparticles by a549 cells[J].Pharm Res,2002,19(10):1488-1494.
  • 5[5]De Campos A M,Sancher A,Alonso M J.Chitosan nanoparticles:A new vehicle for the improvement of the delivery of drugs to the ocular surface.Application to cyclosporin A[J].Int J Pharm,2001,224(1-2):159-168.
  • 6[6]Xu Y,Du Y.Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles[J].Int J Pharm,2001,250(1):215-226.
  • 7[7]Calvo P,Remunan-Lope C,Vila-Jato J L,et al.Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers[J].J Appl Polym Sci,1997,63:125-132.
  • 8[8]El-Shbouri M H.Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A[J].Int J of Pharm,2002,249(1-2):101-108.
  • 9黄小龙,张黎明.壳聚糖基载药纳米微粒制备研究进展[J].功能高分子学报,2003,16(4):593-598. 被引量:21
  • 10[10]H.Q.Mao,K.Ray,S.M.Walsh,et al.DNA-chitosan nanoparticles for the gene delivery.Proc.Load-Intern.Symp.Control.Release.Bioact.Mater.1996(23):401.

二级参考文献30

  • 1[1]Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue [J]. Adv Drug Del Rev, 2003, 55:329 - 347.
  • 2[2]Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanopsphere [J]. Science, 1994, 263:1600 -1603.
  • 3[3]Kawashima Y. Nanoparticulate systems for improved drug delivery [J]. Adv Drug Del Rev 2001,47: 1 - 2.
  • 4[4]Muzzarelli R. Biochemical significance at exogenous chitins and chitosans in animals and patients [J]. Biomaterials, 1993,20:7 - 16.
  • 5[5]Muzzarelli R. Baldassarre V, Coni F. Biological activity of chitosan: Ultrastructural study[J]. Biomaterials, 1988, 9:247 -252.
  • 6[6]Lueben H L, Rental C O, Kotze A F, et al. Mucoadhesivepolymers in peroral peptide drug delivery IV: Polycarbophil andchitosan are potent enhancers of peptide transport acrossintestinal mucosue in vitro [J]. J Contr Rel, 1997, 45: 15 -24.
  • 7[7]Awie F K, Henrik L L, Bas J D, et al. Comparison of the effectof differentchitsoan salts andN-trimethyl chitosan chloride onthepermeability of intestinal epithelial cells (Caco-2) [J]. J Contr Rel, 1998, 51: 35 -43.
  • 8[8]Luessen H L, Leeuw J, Langemegoeer W E, et al. Mucoadhesive polymers in peroral peptide drug delivery V: Carbomer and chitosan improve the intestinal absorption of thepetide drug buserelin in vivo [J]. Pharm Res, 1996,13 (11 ) :1668 -1674.
  • 9[9]Ohya Y, Shiratani M, Kobayashi H, et al. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity [J]. Pure Appl Chem, 1994, A31: 629 -642.
  • 10[10]Tanima B, Susmita M, Singh K, et al. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles [J]. Int J Pharm, 2002, 243 ( 1 - 2 ): 93 - 102.

共引文献20

同被引文献107

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部